- Poster presentation
- Open Access
Drug formulation studies on regulation of BCL-2 family for treatment of autism
© Tayubi et al; licensee BioMed Central Ltd. 2014
- Published: 2 April 2014
- Drug Formulation
- Active Site Residue
- Responsible Target
- Target Component
- Discovery Studio
The admet and chemical properties suggest there are possibilities to consider the new drug complex designed for further analysis.
- Belka C, Budach W: Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology. Int J Radiat Biol. 2002, 78 (8): 643-58.View ArticlePubMedGoogle Scholar
- Helen V, Ratajczak : Theoretical aspects of autism: Causes. A review. Journal of Immunotoxicology. 2011, 8 (1): 68-79.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.